Showing results (31-40 of 79) with videos related to
Sort By:
Pageof 8
Clinicoeconomics and Outcomes Research : CEOR|October 17, 2017
Drug tendering: drug supply and shortage implications for the uptake of biosimilarsGeorge Dranitsaris, Ira Jacobs, Carol Kirchhoff, et al.Pharmacoeconomics|June 30, 2017
Assessing the Value of Biosimilars: A Review of the Role of Budget Impact AnalysisSteven Simoens, Ira Jacobs, Robert Popovian, et al.Journal of the Advanced Practitioner in Oncology|June 29, 2019
Potential of Biosimilars to Increase Access to Biologics: Considerations for Advanced Practice Providers in OncologySara M Tinsley, Carolyn Grande, Karin Olson, et al.Plos One|March 4, 2017
Rate dependent influence of arterial desaturation on self-selected exercise intensity during cyclingSaro D Farra, Stephen S Cheung, Scott G Thomas, et al.Postgraduate Medicine|March 28, 2017
Biosimilar biologic drugs: a new frontier in medical careDaniel M Geynisman, Guillermo De Velasco, K Lea Sewell, et al.Gynecologic Oncology Research and Practice|March 28, 2017
Will bevacizumab biosimilars impact the value of systemic therapy in gynecologic cancers?Bradley J Monk, Warner K Huh, Julie Ann Rosenberg, et al.Biodrugs : Clinical Immunotherapeutics, Biopharmaceuticals and Gene Therapy|November 26, 2016
Biosimilars for the Treatment of Chronic Inflammatory Diseases: A Systematic Review of Published EvidenceIra Jacobs, Danielle Petersel, Leah Isakov, et al.Respiratory Physiology & Neurobiology|May 29, 2016
Clamping end-tidal carbon dioxide during graded exercise with control of inspired oxygenSaro D Farra, Cathie Kessler, James Duffin, et al.The Annals of Pharmacotherapy|February 9, 2017
Biosimilars: Practical Considerations for PharmacistsJames G Stevenson, Robert Popovian, Ira Jacobs, et al.Future Cardiology|March 8, 2024
A mixed-methods landscape assessment of supportive care for heart failureNasir Sulemanjee, Vida Vizgirda, Krishna Naik, et al.Pageof 8